In an in vivo rat model of AD, CM from hypoxic preconditioned MSCs have been shown to decrease brain inflammation (reduction of IL-1β and TNF-α) and Aβ plaques, and to improve neuronal survival and memory deficit [127]. This evidence concerns the gene TNF and Alzheimer disease.